The accumulation of prognostic analysis for clinical features and genome-wide methylome analysis has shown that IDH-wild-type gliomas with these copy number alterations have similar characteristics to glioblastomas, regardless of histological grade [8,121,163]. The gene discussed is IDH2; the disease is central nervous system cancer.